These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37356670)

  • 1. Changes in social, sexual, and hedonic behaviors in rats in response to stress and restoration by a negative allosteric modulator of α5-subunit containing GABA receptor.
    Bailey AM; Barrett A; Havens L; Leyder E; Merchant T; Starnes H; Thompson SM
    Behav Brain Res; 2023 Aug; 452():114554. PubMed ID: 37356670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative Allosteric Modulation of Gamma-Aminobutyric Acid A Receptors at α5 Subunit-Containing Benzodiazepine Sites Reverses Stress-Induced Anhedonia and Weakened Synaptic Function in Mice.
    Troppoli TA; Zanos P; Georgiou P; Gould TD; Rudolph U; Thompson SM
    Biol Psychiatry; 2022 Aug; 92(3):216-226. PubMed ID: 35120711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Negative Allosteric Modulator for α5 Subunit-Containing GABA Receptors Exerts a Rapid and Persistent Antidepressant-Like Action without the Side Effects of the NMDA Receptor Antagonist Ketamine in Mice.
    Zanos P; Nelson ME; Highland JN; Krimmel SR; Georgiou P; Gould TD; Thompson SM
    eNeuro; 2017; 4(1):. PubMed ID: 28275719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Antidepressant Action and Restoration of Excitatory Synaptic Strength After Chronic Stress by Negative Modulators of Alpha5-Containing GABAA Receptors.
    Fischell J; Van Dyke AM; Kvarta MD; LeGates TA; Thompson SM
    Neuropsychopharmacology; 2015 Oct; 40(11):2499-509. PubMed ID: 25900119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basmisanil, an α5-GABA
    Daher F; Villalobos NA; Hanley M; Atack JR; Popa MO; Fogaça MV
    Neurosci Lett; 2024 Jun; 833():137828. PubMed ID: 38772437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of rapid and long-lasting antidepressant effects of negative modulators of α5-containing GABA
    Xiong Z; Zhang K; Ishima T; Ren Q; Chang L; Chen J; Hashimoto K
    Pharmacol Biochem Behav; 2018 Dec; 175():139-145. PubMed ID: 30359627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained treatment with an α5 GABA A receptor negative allosteric modulator delays excitatory circuit development while maintaining GABAergic neurotransmission.
    Nuwer JL; Brady ML; Povysheva NV; Coyne A; Jacob TC
    Neuropharmacology; 2021 Oct; 197():108724. PubMed ID: 34284042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the α5 GABA receptor and 5HTT lead to cognitive deficits associated with major depressive-like behaviors in a 14-day combined stress rat model.
    Ngoupaye GT; Mokgokong M; Madlala T; Mabandla MV
    Int J Neurosci; 2023 Dec; 133(9):959-976. PubMed ID: 34937496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From Inhibition of GABA-A Receptor-Mediated Synaptic Transmission by Conventional Antidepressants to Negative Allosteric Modulators of Alpha5- GABA-A Receptors as Putative Fast-Acting Antidepressant Drugs: Closing the Circle?
    Fernández-Teruel A
    Curr Neuropharmacol; 2022; 20(1):85-89. PubMed ID: 34736382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABA
    Luscher B; Maguire JL; Rudolph U; Sibille E
    Trends Pharmacol Sci; 2023 Sep; 44(9):586-600. PubMed ID: 37543478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of a tonic inhibitory conductance in mouse hippocampal neurones by negative allosteric modulators of α5 subunit-containing γ-aminobutyric acid type A receptors: implications for treating cognitive deficits.
    Manzo MA; Wang DS; Li WW; Pinguelo A; Popa MO; Khodaei S; Atack JR; Ross RA; Orser BA
    Br J Anaesth; 2021 Mar; 126(3):674-683. PubMed ID: 33388140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered γ-aminobutyric acid neurotransmission in major depressive disorder: a critical review of the supporting evidence and the influence of serotonergic antidepressants.
    Pehrson AL; Sanchez C
    Drug Des Devel Ther; 2015; 9():603-24. PubMed ID: 25653499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gamma-Aminobutyric Acid B Receptor in Depression and Reward.
    Jacobson LH; Vlachou S; Slattery DA; Li X; Cryan JF
    Biol Psychiatry; 2018 Jun; 83(11):963-976. PubMed ID: 29759132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA
    Althaus AL; Ackley MA; Belfort GM; Gee SM; Dai J; Nguyen DP; Kazdoba TM; Modgil A; Davies PA; Moss SJ; Salituro FG; Hoffmann E; Hammond RS; Robichaud AJ; Quirk MC; Doherty JJ
    Neuropharmacology; 2020 Dec; 181():108333. PubMed ID: 32976892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative allosteric modulation of alpha 5-containing GABA
    Xu NZ; Ernst M; Treven M; Cerne R; Wakulchik M; Li X; Jones TM; Gleason SD; Morrow D; Schkeryantz JM; Rahman MT; Li G; Poe MM; Cook JM; Witkin JM
    Psychopharmacology (Berl); 2018 Apr; 235(4):1151-1161. PubMed ID: 29374303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hypothesis of monoamine (5-HT) - Glutamate/GABA long neural circuit: Aiming for fast-onset antidepressant discovery.
    Li YF
    Pharmacol Ther; 2020 Apr; 208():107494. PubMed ID: 31991195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation.
    Fee C; Prevot TD; Misquitta K; Knutson DE; Li G; Mondal P; Cook JM; Banasr M; Sibille E
    Int J Neuropsychopharmacol; 2021 Jul; 24(6):505-518. PubMed ID: 33438026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A question of balance--positive versus negative allosteric modulation of GABA(A) receptor subtypes as a driver of analgesic efficacy in rat models of inflammatory and neuropathic pain.
    Munro G; Erichsen HK; Rae MG; Mirza NR
    Neuropharmacology; 2011; 61(1-2):121-32. PubMed ID: 21439986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
    Cutler AJ; Mattingly GW; Maletic V
    Transl Psychiatry; 2023 Jun; 13(1):228. PubMed ID: 37365161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.